Healthcare provider profile · identity verified

Gregory D Reckamp, M.D.

Family Practice · OREGON, IL · NPI 1649248543

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	710	160
Losartan Potassium	Losartan Potassium	479	104
Gabapentin	Gabapentin	463	81
Amlodipine Besylate	Amlodipine Besylate	410	98
Levothyroxine Sodium	Levothyroxine Sodium	396	73
Lisinopril	Lisinopril	343	78
Omeprazole	Omeprazole	317	69
Tamsulosin Hcl	Tamsulosin Hcl	261	50
Metformin Hcl	Metformin Hcl	258	52
Metoprolol Succinate	Metoprolol Succinate	249	67
Furosemide	Furosemide	219	53
Tramadol Hcl	Tramadol Hcl	218	70
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	205	46
Eliquis	Apixaban	203	26
Escitalopram Oxalate	Escitalopram Oxalate	196	36
Metoprolol Tartrate	Metoprolol Tartrate	176	41
Pregabalin	Pregabalin	171	37
Trazodone Hcl	Trazodone Hcl	162	35
Hydrochlorothiazide	Hydrochlorothiazide	161	43
Potassium Chloride	Potassium Chloride	160	28
Pantoprazole Sodium	Pantoprazole Sodium	154	38
Duloxetine Hcl	Duloxetine Hcl	147	24
Oxybutynin Chloride Er	Oxybutynin Chloride	137	19
Prednisone	Prednisone	130	61
Sertraline Hcl	Sertraline Hcl	123	23
Venlafaxine Hcl Er	Venlafaxine Hcl	118	18
Lorazepam	Lorazepam	105	23
Buspirone Hcl	Buspirone Hcl	103	20
Albuterol Sulfate Hfa	Albuterol Sulfate	101	35
Jardiance	Empagliflozin	95	17
Mirtazapine	Mirtazapine	92	22
Pioglitazone Hcl	Pioglitazone Hcl	90	17
Finasteride	Finasteride	85	22
Meloxicam	Meloxicam	85	26
Simvastatin	Simvastatin	84	23
Clonazepam	Clonazepam	83	suppressed
Famotidine	Famotidine	81	13
Rosuvastatin Calcium	Rosuvastatin Calcium	80	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	79	27
Cephalexin	Cephalexin	78	29
Alendronate Sodium	Alendronate Sodium	75	15
Metformin Hcl Er	Metformin Hcl	73	16
Citalopram Hbr	Citalopram Hydrobromide	71	17
Spironolactone	Spironolactone	69	17
Alprazolam	Alprazolam	66	21
Esomeprazole Magnesium	Esomeprazole Magnesium	66	11
Fentanyl	Fentanyl	66	suppressed
Clopidogrel	Clopidogrel Bisulfate	65	20
Fluticasone Propionate	Fluticasone Propionate	65	16
Chlorthalidone	Chlorthalidone	64	14
Ropinirole Hcl	Ropinirole Hcl	64	17
Primidone	Primidone	63	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	16
Allopurinol	Allopurinol	61	14
Zolpidem Tartrate	Zolpidem Tartrate	61	21
Montelukast Sodium	Montelukast Sodium	58	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	56	suppressed
Nystatin	Nystatin	55	18
Bupropion Xl	Bupropion Hcl	47	11
Januvia	Sitagliptin Phosphate	46	suppressed
Topiramate	Topiramate	46	suppressed
Ozempic	Semaglutide	44	suppressed
Carvedilol	Carvedilol	43	12
Ondansetron Hcl	Ondansetron Hcl	43	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	42	suppressed
Levetiracetam	Levetiracetam	42	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	40	suppressed
Glipizide	Glipizide	39	11
Triamcinolone Acetonide	Triamcinolone Acetonide	39	25
Xarelto	Rivaroxaban	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Latanoprost	Latanoprost	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Mounjaro	Tirzepatide	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Myrbetriq	Mirabegron	35	suppressed
Atenolol	Atenolol	33	suppressed
Divalproex Sodium	Divalproex Sodium	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Ondansetron Odt	Ondansetron	29	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	28	suppressed
Diazepam	Diazepam	28	suppressed
Humulin R	Insulin Regular, Human	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	24
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Baclofen	Baclofen	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Arnuity Ellipta	Fluticasone Furoate	25	suppressed
Phenobarbital	Phenobarbital	25	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	24	suppressed
Lacosamide	Lacosamide	24	suppressed
Terbinafine Hcl	Terbinafine Hcl	24	suppressed
Tresiba Flextouch U-200	Insulin Degludec	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	21
Klor-Con M20	Potassium Chloride	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	19
Propranolol Hcl	Propranolol Hcl	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Brilinta	Ticagrelor	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Fenofibrate	Fenofibrate,micronized	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	16
Fenofibrate	Fenofibrate	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Nitroglycerin	Nitroglycerin	18	suppressed
Febuxostat	Febuxostat	17	suppressed
Nyamyc	Nystatin	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Albuterol Sulfate	Albuterol Sulfate	16	suppressed
Amoxicillin	Amoxicillin	16	11
Anastrozole	Anastrozole	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Carbamazepine	Carbamazepine	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Nabumetone	Nabumetone	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Bumetanide	Bumetanide	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	14	suppressed
Cilostazol	Cilostazol	13	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	13	12
Rybelsus	Semaglutide	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Desogestr-Eth Estrad Eth Estra	Desog-E.Estradiol/E.Estradiol	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Kurvelo	Levonorgestrel/Ethin.Estradiol	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Multaq	Dronedarone Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Linzess	Linaclotide	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Sure Comfort	Pen Needle, Diabetic	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error